A novel antiestrogen, TAS-108 (SR16234) shows full antagonistic activity to ER alpha and beta with a unique mechanism - Yamamoto, Y.; Wada, O.; Yanagisawa, J.; Kato, S.; Kitazato, K. (European Journal of Cancer, 2002)